Hepatitis b virus and primary hepatocellular carcinoma

W. Thomas London, Kenneth Buetow

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Primary hepatocellular carcinoma (PHC), although relatively uncommon in the United States and western countries, is one of the three most common causes of cancer mortality in the world, accounting for 250,000 to 1,000,000 deaths per year (1). In Taiwan, it is the leading cause of death for men over 40 years of age (30/100,000/yr at age 40 rising to 100/100,000/yr at age 60) (2). Even in the United States, there are about 5,000 deaths per year from PHC, giving an age-adjusted annual mortality of 2.2/100,000, which is three times that of Hodgkin's disease (0.7/100,000) (3). The incidence of PHC is essentially the same as the mortality, the five-year survival being in the 2-3 % range. Thus far, the only therapy that appears to improve survival is the resection of small (less than 3 cm in diameter) asymptomatic tumors (4).

Original languageEnglish (US)
Pages (from-to)317-326
Number of pages10
JournalCancer Investigation
Volume6
Issue number3
DOIs
StatePublished - 1988
Externally publishedYes

Fingerprint

Hepatitis Viruses
Hepatocellular Carcinoma
Mortality
Survival
Hodgkin Disease
Taiwan
Cause of Death
Neoplasms
Incidence
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Hepatitis b virus and primary hepatocellular carcinoma. / London, W. Thomas; Buetow, Kenneth.

In: Cancer Investigation, Vol. 6, No. 3, 1988, p. 317-326.

Research output: Contribution to journalArticle

London, W. Thomas ; Buetow, Kenneth. / Hepatitis b virus and primary hepatocellular carcinoma. In: Cancer Investigation. 1988 ; Vol. 6, No. 3. pp. 317-326.
@article{2444566ed7f44613881f42df59a18e5e,
title = "Hepatitis b virus and primary hepatocellular carcinoma",
abstract = "Primary hepatocellular carcinoma (PHC), although relatively uncommon in the United States and western countries, is one of the three most common causes of cancer mortality in the world, accounting for 250,000 to 1,000,000 deaths per year (1). In Taiwan, it is the leading cause of death for men over 40 years of age (30/100,000/yr at age 40 rising to 100/100,000/yr at age 60) (2). Even in the United States, there are about 5,000 deaths per year from PHC, giving an age-adjusted annual mortality of 2.2/100,000, which is three times that of Hodgkin's disease (0.7/100,000) (3). The incidence of PHC is essentially the same as the mortality, the five-year survival being in the 2-3 {\%} range. Thus far, the only therapy that appears to improve survival is the resection of small (less than 3 cm in diameter) asymptomatic tumors (4).",
author = "London, {W. Thomas} and Kenneth Buetow",
year = "1988",
doi = "10.3109/07357908809080654",
language = "English (US)",
volume = "6",
pages = "317--326",
journal = "Cancer Investigation",
issn = "0735-7907",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Hepatitis b virus and primary hepatocellular carcinoma

AU - London, W. Thomas

AU - Buetow, Kenneth

PY - 1988

Y1 - 1988

N2 - Primary hepatocellular carcinoma (PHC), although relatively uncommon in the United States and western countries, is one of the three most common causes of cancer mortality in the world, accounting for 250,000 to 1,000,000 deaths per year (1). In Taiwan, it is the leading cause of death for men over 40 years of age (30/100,000/yr at age 40 rising to 100/100,000/yr at age 60) (2). Even in the United States, there are about 5,000 deaths per year from PHC, giving an age-adjusted annual mortality of 2.2/100,000, which is three times that of Hodgkin's disease (0.7/100,000) (3). The incidence of PHC is essentially the same as the mortality, the five-year survival being in the 2-3 % range. Thus far, the only therapy that appears to improve survival is the resection of small (less than 3 cm in diameter) asymptomatic tumors (4).

AB - Primary hepatocellular carcinoma (PHC), although relatively uncommon in the United States and western countries, is one of the three most common causes of cancer mortality in the world, accounting for 250,000 to 1,000,000 deaths per year (1). In Taiwan, it is the leading cause of death for men over 40 years of age (30/100,000/yr at age 40 rising to 100/100,000/yr at age 60) (2). Even in the United States, there are about 5,000 deaths per year from PHC, giving an age-adjusted annual mortality of 2.2/100,000, which is three times that of Hodgkin's disease (0.7/100,000) (3). The incidence of PHC is essentially the same as the mortality, the five-year survival being in the 2-3 % range. Thus far, the only therapy that appears to improve survival is the resection of small (less than 3 cm in diameter) asymptomatic tumors (4).

UR - http://www.scopus.com/inward/record.url?scp=0023683746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023683746&partnerID=8YFLogxK

U2 - 10.3109/07357908809080654

DO - 10.3109/07357908809080654

M3 - Article

C2 - 2844364

AN - SCOPUS:0023683746

VL - 6

SP - 317

EP - 326

JO - Cancer Investigation

JF - Cancer Investigation

SN - 0735-7907

IS - 3

ER -